NCT00989235View on ClinicalTrials.gov

Substudy - Low Dose of Abatacept in Subjects With Rheumatoid Arthritis

PHASE3CompletedINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2009

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Abatacept

IV solution, IV, 10 mg/Kg, Once monthly, 1 year

DRUG

Abatacept

IV solution, IV, 5 mg/Kg, Once monthly, 1 year

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT00989235 - Substudy - Low Dose of Abatacept in Subjects With Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter